Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 246

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic

Open access
Mendrick, Donna L, Diehl, Anna Mae, Topor, Lisa S, Dietert, Rodney R, Will, Yvonne, La Merrill, Michele A, Bouret, Sebastien, Varma, Vijayalaskshmi, Hastings, Kenneth L, Schug, Thaddeus T, Emeigh Hart, Susan G, Burleson, Florence G · 2018 · Toxicological Sciences

Abstract

Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic, a Society of Toxicology Contemporary Concepts in Toxicology (CCT) workshop was held on March 11, 2017. The meeting was convened to raise awareness of metabolic syndrome and its associated diseases and serve as a melting pot with scientists of multiple disciplines (eg, toxicologists, clinicians, regulators) so as to spur research and understanding of this condition. The criteria for metabolic syndrome include obesity, dyslipidemia (low high-density lipoprotein and/or elevated triglycerides), elevated blood pressure, and alterations in glucose metabolism. It can lead to a greater potential of type 2 diabetes, lipid disorders, cardiovascular disease, hepatic steatosis, and other circulatory disorders. Although there are no approved drugs specifically for this syndrome, many drugs target diseases associated with this syndrome thus potentially increasing the likelihood of drug-drug interactions. There is currently significant research focusing on understanding the key pathways that control metabolism, which would be likely targets of risk factors (eg, exposure to xenobiotics, genetics) and lifestyle factors (eg, microbiome, nutrition, and exercise) that contribute to metabolic syndrome. Understanding these pathways could also lead to the development of pharmaceutical interventions. As individuals with metabolic syndrome have signs similar to that of toxic responses (eg, oxidative stress and inflammation) and organ dysfunction, these alterations should be taken into account in drug development. With the increasing frequency of metabolic syndrome in the general population, the idea of a "normal" individual may need to be redefined. This paper reports on the substance and outcomes of this workshop.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/toxsci/kfx233

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 42

  1. Anuurad, 2009, Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease, Metab. Syndr. Relat. Disord., 7, 401, 10.1089/met.2008.0096 · DOI
  2. Bray, 2016, NIH working group report-using genomic information to guide weight management: From universal to precision treatment, Obesity (Silver Spring), 24, 14, 10.1002/oby.21381 · DOI · Paper page
  3. Cano-Sancho, 2017, Association between exposure to p,p′-DDT and its metabolite p,p′-DDE with obesity: Integrated systematic review and meta-analysis, Environ. Health Perspect., 10.1289/EHP527 · DOI
  4. Cunningham, 2014, Incidence of childhood obesity in the United States, N. Engl. J. Med., 370, 1660, 10.1056/NEJMoa1309753 · DOI · Paper page
  5. Desai, 2015, Epigenomics, gestational programming and risk of metabolic syndrome, Int. J. Obes. (Lond.), 39, 633, 10.1038/ijo.2015.13 · DOI · Paper page
  6. Eskenazi, 2009, The Pine River statement: Human health consequences of DDT use, Environ. Health Perspect., 117, 1359, 10.1289/ehp.11748 · DOI · Paper page
  7. Eskenazi, 2006, In utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethylene (DDE) and neurodevelopment among young Mexican American children, Pediatrics, 118, 233, 10.1542/peds.2005-3117 · DOI · Paper page
  8. Evangelou, 2016, Exposure to pesticides and diabetes: A systematic review and meta-analysis, Environ. Int., 91, 60, 10.1016/j.envint.2016.02.013 · DOI · Paper page
  9. Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 528, 262, 10.1038/nature15766 · DOI · Paper page
  10. Fromenty, 2013, Drug-induced liver injury in obesity, J. Hepatol., 58, 824, 10.1016/j.jhep.2012.12.018 · DOI
  11. Gaillard, 2015, Maternal weight gain in different periods of pregnancy and childhood cardio-metabolic outcomes. The Generation R Study, Int. J. Obes. (Lond.), 39, 677, 10.1038/ijo.2014.175 · DOI · Paper page
  12. Glavas, 2010, Early overnutrition results in early-onset arcuate leptin resistance and increased sensitivity to high-fat diet, Endocrinology, 151, 1598, 10.1210/en.2009-1295 · DOI · Paper page
  13. Grundy, 2008, Metabolic syndrome pandemic, Arterioscler. Thromb. Vasc. Biol., 28, 629, 10.1161/ATVBAHA.107.151092 · DOI · Paper page
  14. Herrera-Portugal, 2005, Environmental pathways of exposure to DDT for children living in a malarious area of Chiapas, Mexico, Environ. Res., 99, 158, 10.1016/j.envres.2005.03.010 · DOI · Paper page
  15. Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat. Med., 19, 576, 10.1038/nm.3145 · DOI · Paper page
  16. Korem, 2015, Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples, Science, 349, 1101, 10.1126/science.aac4812 · DOI · Paper page
  17. Kraja, 2014, Pleiotropic genes for metabolic syndrome and inflammation, Mol. Genet. Metab., 112, 317, 10.1016/j.ymgme.2014.04.007 · DOI
  18. Kramer, 2016, Geography of adolescent obesity in the U.S., 2007–2011, Am. J. Prev. Med., 51, 898, 10.1016/j.amepre.2016.06.016 · DOI
  19. La Merrill, 2014, Perinatal exposure of mice to the pesticide DDT impairs energy expenditure and metabolism in adult female offspring, PLoS One, 9, e103337., 10.1371/journal.pone.0103337 · DOI · Paper page
  20. La Merrill, 2016, Perinatal DDT exposure induces hypertension and cardiac hypertrophy in adult mice, Environ. Health Perspect., 124, 1722, 10.1289/EHP164 · DOI
  21. Lim, 2009, Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance, PLoS One, 4, e5186., 10.1371/journal.pone.0005186 · DOI · Paper page
  22. Lumeng, 2013, Innate immune activation in obesity, Mol. Aspects Med., 34, 12, 10.1016/j.mam.2012.10.002 · DOI
  23. Malagon, 2013, Adipobiology for novel therapeutic approaches in metabolic syndrome, Curr. Vasc. Pharmacol., 11, 954, 10.2174/15701611113116660170 · doi:10.2174/15701611113116660170
  24. Marotz, 2016, Treating obesity and metabolic syndrome with fecal microbiota transplantation, Yale J. Biol. Med., 89, 383
  25. Montgomery, 2015, Mitochondrial dysfunction and insulin resistance: An update, Endocr. Connect., 4, R1, 10.1530/EC-14-0092 · DOI · Paper page
  26. Mullins, 2017, Acute sleep restriction increases dietary intake in preschool-age children, J. Sleep Res., 26, 48, 10.1111/jsr.12450 · DOI
  27. Nassir, 2014, Role of mitochondria in nonalcoholic fatty liver disease, Int. J. Mol. Sci., 15, 8713, 10.3390/ijms15058713 · DOI · Paper page
  28. Park, 2008, A mitochondrial DNA variant at position 16189 is associated with type 2 diabetes mellitus in Asians, Diabetologia, 51, 602, 10.1007/s00125-008-0933-z · DOI
  29. Park, 2016, Body burden of persistent organic pollutants on hypertension: A meta-analysis, Environ. Sci. Pollut. Res. Int., 23, 14284, 10.1007/s11356-016-6568-6 · DOI
  30. Plagemann, 2006, Perinatal nutrition and hormone-dependent programming of food intake, Horm. Res, 65, 83
  31. Pravenec, 2007, Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains, Genome Res., 17, 1319, 10.1101/gr.6548207 · DOI
  32. Sell, 2012, Adaptive immunity in obesity and insulin resistance, Nat. Rev. Endocrinol., 8, 709, 10.1038/nrendo.2012.114 · DOI · Paper page
  33. Song, 2016, Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: A systematic review and meta-analysis, J. Diabetes, 8, 516, 10.1111/1753-0407.12325 · DOI · Paper page
  34. Sunny, 2017, Mitochondrial adaptation in nonalcoholic fatty liver disease: Novel mechanisms and treatment strategies, Trends Endocrinol. Metab., 28, 250, 10.1016/j.tem.2016.11.006 · DOI · Paper page
  35. Tang-Peronard, 2011, Endocrine-disrupting chemicals and obesity development in humans: A review, Obes. Rev., 12, 622, 10.1111/j.1467-789X.2011.00871.x · DOI · Paper page
  36. Tariq, 2016, Non-alcoholic fatty pancreatic disease: A review of literature, Gastroenterol. Res., 9, 87, 10.14740/gr731w · DOI
  37. Tornatore, 2012, The nuclear factor kappa B signaling pathway: Integrating metabolism with inflammation, Trends Cell Biol., 22, 557, 10.1016/j.tcb.2012.08.001 · DOI · Paper page
  38. Toubal, 2013, Genomic and epigenomic regulation of adipose tissue inflammation in obesity, Trends Endocrinol. Metab., 24, 625, 10.1016/j.tem.2013.09.006 · DOI
  39. Wang, 2016, Weight gain in infancy and overweight or obesity in childhood across the gestational spectrum: A prospective birth cohort study, Sci. Rep., 6, 29867., 10.1038/srep29867 · DOI
  40. Wang, 2016, Do environmental pollutants increase obesity risk in humans?, Obes. Rev., 17, 1179, 10.1111/obr.12463 · DOI
  41. Whitaker, 1997, Predicting obesity in young adulthood from childhood and parental obesity, N. Engl. J. Med, 337, 869, 10.1056/NEJM199709253371301 · DOI · Paper page
  42. Wolff, 2007, Pharmacokinetic variability and modern epidemiology: The example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort, Cancer Epidemiol. Biomarkers Prev., 16, 1925, 10.1158/1055-9965.EPI-07-0394 · DOI

Cited by

See all 246

Metadata

Authors
Mendrick, D. L., Diehl, A. M., Topor, L. S., Dietert, R. R., Will, Y., La Merrill, M. A., Bouret, S., Varma, V., Hastings, K. L., Schug, T. T., Emeigh Hart, S. G., & Burleson, F. G.
Venue
Toxicological Sciences
Published
2017-11-02
Volume
162
Issue
1
Pages
36-42
ISSN
  • 1096-0929 (ISSN-L)
  • 1096-6080
OpenAlex
W2765151872
Cited by
246
References
19
FWCI
10.21
Type
journal article
Language
en
Open access
hybrid
Funders
National Institute of Environmental Health Sciences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.